Purified anti-ILK Antibody anti-ILK - P83A9,BioLegend,694902

Host

Mouse

Reactivity

Human, Mouse

Application

WB -Quality testedKO/KD-WB, ICC -Verified

Platform ID

BAB702853257

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-ILK Antibody anti-ILK - P83A9
Cat. No.694902
HostMouse
RRIDAB_2650742 (BioLegend Cat. No. 694901)AB_2650743 (BioLegend Cat. No. 694902)
IsotypeMouse IgG1, κ
ReactivityHuman, Mouse
ApplicationWB -Quality testedKO/KD-WB, ICC -Verified
ClonalityMonoclonal
Clone NumberP83A9
Concentration0.5 mg/ml
TargetILK
ImmunogenPurified recombinant of ILK (aa: 97-224) expressed inE.Coli.
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Integrin-linked kinase (ILK) is an integrin associated actin and tubulin cytoskeletal interacting effector. ILK was identified in a search for proteins interacting with integrin β CTs. It has an N-terminal ankyrin repeat domain (ARD) and a C-terminal integrin β CT binding kinase-like domain (KLD). ILK functions as a key scaffold at cell-ECM adhesions and regulates integrin-mediated as well as growth factor regulated functions. ILK orchestrates several signaling pathways, such as PI3Kinase/Akt, Wnt, TGF-β, Hippo tumor suppressor pathway and epithelial-mesenchymal transition signaling in various types of cancer cells. ILK expression is upregulated in many types of cancers.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.